Multisite Is Superior to Single-Site Intratumoral Chemotherapy to Retard the Outcomes of Pancreatic Ductal Adenocarcinoma in a Murine Model

Multisite Is Superior to Single-Site Intratumoral Chemotherapy to Retard the Outcomes of Pancreatic Ductal Adenocarcinoma in a Murine Model

Introduction: Locally advanced unresectable pancreatic cancer (LAPC) has a dismal prognosis, with intratumoral therapies showing limited benefits. We assume that the dense stroma within these tumors hampers drug dispersion. Aim: This study explores the efficacy of multisite intratumoral injections i...

Full description

Bibliographic Details
Main Authors: Janette Lazarovits, Ron Epelbaum, Jesse Lachter, Yaron Amikam, Jacob Ben Arie
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Cancers
Subjects:
EUS-FNA
drug delivery
LAPC
stroma
Online Access:https://www.mdpi.com/2072-6694/15/24/5801

Internet

https://www.mdpi.com/2072-6694/15/24/5801

Similar Items